These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 20353028

  • 1. [Effect of liangxue shengji recipe on incidence of post-percutaneous coronary intervention restenosis and adverse cardiovascular events].
    Cui XY, Wu Y, Nong YB.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jan; 30(1):30-2. PubMed ID: 20353028
    [Abstract] [Full Text] [Related]

  • 2. XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China.
    Chen KJ, Shi DZ, Xu H, Lü SZ, Li TC, Ke YN, Zhang MZ, Lu XY, Sun RY, You SJ.
    Chin Med J (Engl); 2006 Jan 05; 119(1):6-13. PubMed ID: 16454975
    [Abstract] [Full Text] [Related]

  • 3. [Clinical study on effect of xiongshao capsule on restenosis after percutaneous coronary intervention].
    Lu XY, Shi DZ, Xu H.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Jan 05; 26(1):13-7. PubMed ID: 16466165
    [Abstract] [Full Text] [Related]

  • 4. A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule in preventing restenosis after percutaneous coronary intervention: a subgroup analysis of senile patients.
    Shang QH, Xu H, Lu XY, Wen C, Shi DZ, Chen KJ.
    Chin J Integr Med; 2011 Sep 05; 17(9):669-74. PubMed ID: 21910067
    [Abstract] [Full Text] [Related]

  • 5. [Study on correlation of blood-stasis syndrome and its accompanied syndromes with pathological changes showed in coronary angiography and restenosis after percutaneous coronary intervention].
    Xu H, Lu XY, Chen KJ.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jan 05; 27(1):8-13. PubMed ID: 17302055
    [Abstract] [Full Text] [Related]

  • 6. Direct drug-eluting stenting to reduce stent restenosis: a randomized comparison of direct stent implantation to conventional stenting with pre-dilation or provisional stenting in elective PCI patients.
    Remkes WS, Somi S, Roolvink V, Rasoul S, Ottervanger JP, Gosselink AT, Hoorntje JC, Dambrink JH, de Boer MJ, Suryapranata H, van 't Hof AW, Acute Myocardial Infarction Study Group.
    JACC Cardiovasc Interv; 2014 Jul 05; 7(7):751-8. PubMed ID: 25060017
    [Abstract] [Full Text] [Related]

  • 7. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome.
    Chyrchel M, Rakowski T, Rzeszutko L, Legutko J, Dziewierz A, Dubiel JS, Dudek D.
    Kardiol Pol; 2006 Dec 05; 64(12):1357-62; discussion 1363. PubMed ID: 17206539
    [Abstract] [Full Text] [Related]

  • 8. [Effect of intracoronary injection with xuesaitong in treating post-PCI slow-reflow phenomenon in patients with ST-segment elevation myocardial infarction].
    Gan LJ, Zhang CH, Zhang M.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Apr 05; 30(4):348-51. PubMed ID: 20669666
    [Abstract] [Full Text] [Related]

  • 9. [Effect of shuxuetong in preventing restenosis after intracoronary stenting].
    Li AH, Gong KZ, Yan JF, Sun X, Feng Y, Zhang Z.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Oct 05; 24(10):879-81. PubMed ID: 15553817
    [Abstract] [Full Text] [Related]

  • 10. First experience with hybrid percutaneous transmyocardial laser revascularization and angioplasty in patients with lesions at high risk for restenosis: Results of a phase I feasibility study.
    Stone GW, St Goar FG, Taussig A, Power JA, Kosinski E, Shawl F.
    Am Heart J; 2001 Oct 05; 142(4):679-83. PubMed ID: 11579359
    [Abstract] [Full Text] [Related]

  • 11. Chinese Herbal Medicines for Restenosis After Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials.
    Wu J, Zhao L, Lin K, Lu L, Luo C.
    J Altern Complement Med; 2019 Oct 05; 25(10):983-992. PubMed ID: 31464515
    [Abstract] [Full Text] [Related]

  • 12. [Association between fasting plasma glucose and the 5 years outcome post PCI in aged patients with coronary artery disease].
    Su HY, Pan CY, Liu M, Jin MM.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Aug 05; 36(8):710-3. PubMed ID: 19100112
    [Abstract] [Full Text] [Related]

  • 13. Incidence of definite stent thrombosis or in-stent restenosis after drug-eluting stent implantation for treatment of coronary in-stent restenosis: from Western Denmark Heart Registry.
    Jensen JK, Jensen LO, Terkelsen CJ, Lassen JF, Tilsted HH, Hansen KN, Maeng M, Thuesen L, Thayssen P.
    Catheter Cardiovasc Interv; 2013 Feb 05; 81(2):260-5. PubMed ID: 22511512
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation on clinical effect of long-term shexiang baoxin pill administration for treatment of coronary heart disease].
    Zhu H, Luo XP, Wang LJ.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 May 05; 30(5):474-7. PubMed ID: 20681275
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the efficacy and safety of pharmacological treatment versus percutaneous coronary angioplasty in patients with intermediate coronary artery lesions.
    Latacz P, Rostoff P, Gackowski A, El-Massri N, Konduracka E, Gajos G, Matysek J, Piwowarska W, Zmudka K.
    Kardiol Pol; 2009 Aug 05; 67(8A):1004-12. PubMed ID: 19784905
    [Abstract] [Full Text] [Related]

  • 16. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
    Takagi K, Ielasi A, Shannon J, Latib A, Godino C, Davidavicius G, Mussardo M, Ferrarello S, Figini F, Carlino M, Montorfano M, Chieffo A, Nakamura S, Colombo A.
    Circ Cardiovasc Interv; 2012 Aug 01; 5(4):491-8. PubMed ID: 22851528
    [Abstract] [Full Text] [Related]

  • 17. [Effect of Tongguan capsule on post-intervention patients of coronary heart disease with qi-deficiency and blood stasis syndrome].
    Li J, Zhang MZ, Chen BJ.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Jan 01; 28(1):32-5. PubMed ID: 18418966
    [Abstract] [Full Text] [Related]

  • 18. [Turbid-phlegm is an important pathogenesis of restenosis after percutaneous transluminal coronary intervention].
    Wang DY, Jin HG.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2005 Aug 01; 25(8):750-3. PubMed ID: 16152841
    [Abstract] [Full Text] [Related]

  • 19. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W, Lopes NH, Gersh BJ, Soares P, Machado LA, Jatene FB, Oliveira SA, Ramires JA.
    Circulation; 2007 Mar 06; 115(9):1082-9. PubMed ID: 17339566
    [Abstract] [Full Text] [Related]

  • 20. [Integrative medical intervention strategies for recurrent angina after coronary revascularization].
    Chen P, Wang L, Zhang J.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Dec 06; 30(12):1237-40. PubMed ID: 21302480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.